New Case Study Highlights Ability of bioAffinity Technologies' CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer

Core Insights - The case study highlights how CyPath Lung technology can help avoid invasive procedures for elderly patients with suspicious lung nodules detected via CT scans [1] Company Overview - CyPath Lung is positioned as a non-invasive solution for lung nodule assessment, potentially improving patient outcomes and reducing healthcare costs associated with invasive diagnostic procedures [1]